News
10don MSN
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
ResMed has previously shrugged off concerns over weight-loss drugs such as Novo Nordisk's (NOVOb.CO), opens new tab Wegovy and Eli Lilly's Zepbound being tested to treat sleep apnea. Shares of the ...
There is no direct mention of Wegovy in the videos or stories, though Novo Nordisk’s logo is on the website. Novo hasn’t had it easy with the drug, however. In December 2021, the pharma said ...
Novo Nordisk's hopes of heralding a new era of obesity treatment with its CagriSema drug have been called into question after a series of trial results sent shares falling. Headline results from a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results